Liver fibrosis could be treated with gold nanoparticles
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of simva1
Researchers from the IDIBAPS and the Institute of Neurosciences of the University of Barcelona (UBNeuro) described a mechanism, the increase of prote1
Researchers of the Hospital Clínic-IDIBAPS and the Josep Carreras Leukemia Research Institute have developed a new technique that allows detecting an1
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of1
The program provides beneficiaries - all of them brilliant postdoctoral professionals - with the opportunity to dedicate themselves fully to biomedic1
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the IDIBAPS have identified a group of1
The continuous inflammation of some tissues, such as liver, pancreas or colon, is a known risk factor for the development of certain types of cancer.1
Researchers at IDIBAPS have published a study in Nature Communications in which they have deciphered the molecular basis of the genetic predispositio1
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before t1